We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

674 hedge funds and large institutions have $39.7B invested in Allergan plc in 2014 Q2 according to their latest regulatory filings, with 103 funds opening new positions, 272 increasing their positions, 223 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more first-time investments, than exits

New positions opened: 103 | Existing positions closed: 52

77% more call options, than puts

Call options by funds: $1.11B | Put options by funds: $627M

22% more repeat investments, than reductions

Existing positions increased: 272 | Existing positions reduced: 223

19% more capital invested

Capital invested by funds: $33.3B → $39.7B (+$6.35B)

15% more funds holding in top 10

Funds holding in top 10: 7384 (+11)

7% more funds holding

Funds holding: 628674 (+46)

Holders
674
Holders Change
+46
Holders Change %
+7.32%
% of All Funds
19.37%
Holding in Top 10
84
Holding in Top 10 Change
+11
Holding in Top 10 Change %
+15.07%
% of All Funds
2.41%
New
103
Increased
272
Reduced
223
Closed
52
Calls
$1.11B
Puts
$627M
Net Calls
+$482M
Net Calls Change
+$56.9M
Name Holding Trade Value Shares
Change
Change in
Stake
QC
701
QCM Cayman
Texas
-$640K -3,110 Closed
HCM
702
Highbridge Capital Management
New York
-$643K -3,106 Closed
WMSA
703
Weiss Multi-Strategy Advisers
New York
-$576K -2,800 Closed
QSS
704
Quantitative Systematic Strategies
Florida
-$428K -2,097 Closed
CIM
705
CenturyLink Investment Management
Colorado
-$419K -2,034 Closed
DCM
706
Dynamic Capital Management
Jersey
-$412K -2,001 Closed
DFIM
707
Detwiler Fenton Investment Management
Massachusetts
-$407K -1,975 Closed
CL
708
CSS LLC
Illinois
-$350K -1,700 Closed
Lazard Asset Management
709
Lazard Asset Management
New York
-$311K -1,512 Closed
AG
710
Algert Global
California
-$284K -1,380 Closed
TRCT
711
Tower Research Capital (TRC)
New York
-$274K -1,327 Closed
Grantham, Mayo, Van Otterloo & Co (GMO)
712
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
-$269K -1,306 Closed
TAM
713
Telluride Asset Management
Minnesota
-$261K -1,269 Closed
NIM
714
NuWave Investment Management
New Jersey
-$232K -1,126 Closed
GI
715
Gradient Investments
Minnesota
-$212K -1,032 Closed
PSC
716
Piper Sandler & Co
Minnesota
-$206K -1,000 Closed
IPRC
717
Indices-Pac Research Corporation
New Jersey
-$201K -978 Closed
PA
718
Perceptive Advisors
New York
-$195K -945 Closed
CC
719
Coastland Capital
California
-$104K -500 Closed
CL
720
CFS LLC
Oklahoma
-$97K -470 Closed
PP
721
Palladium Partners
Virginia
-$82K -400 Closed
AR
722
Advisory Research
Illinois
-$64K -312 Closed
MCM
723
McKinley Capital Management
Alaska
-$56K -271 Closed
AUB
724
Atlantic Union Bankshares
Virginia
-$12K -86 Closed
MUMSS
725
Mitsubishi UFJ Morgan Stanley Securities
Japan
-$14K -70 Closed

AGN Hedge Fund Activity: Q2 2014 in Review

674 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q2 2014, worth a combined $39.7B — up 19% from $33.3B a quarter earlier.

Buyers outnumbered sellers: 103 funds opened new AGN positions and 52 closed out — a net gain of 51 holders — while 272 added to existing stakes and 223 trimmed.

The largest buyer was Jana Partners, adding an estimated $363M. The largest seller was York Capital Management Global Advisors, exiting entirely with an estimated $198M sold.

  • 674 institutional investors held Allergan plc (AGN) as of Q2 2014, up from 628 in Q1 2014.
  • Funds reported $39.7B of Allergan plc stock for Q2 2014, up 19% quarter-over-quarter.
  • 103 funds opened new Allergan plc positions in Q2 2014 and 52 closed out, a net change of +51 holders.
  • The largest Allergan plc buyer in Q2 2014 was Jana Partners, an estimated $363M added.
  • The largest Allergan plc seller in Q2 2014 was York Capital Management Global Advisors, an estimated $198M sold.

Based on aggregated 13F filings for Q2 2014.